Avoidance of apoptosis as a mechanism of drug resistance

Journal of Internal Medicine, Supplement

Volumn 242, Issue 740, 1997, Pages 139-145

  Dive, C ^a  

^a School of Biological Sciences   (United Kingdom)

Author keywords

Apoptosis survival signals; bcl 2 family; Death domains; DNA damage; Drug resistance

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ENDONUCLEASE; FAS ANTIGEN; DNA;

APOPTOSIS; CELL SURVIVAL; CONFERENCE PAPER; DNA ALKYLATION; DNA DAMAGE; DNA REPAIR; DRUG DETOXIFICATION; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; MITOCHONDRIAL MEMBRANE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; CELL CULTURE; DRUG EFFECT; DRUG RESISTANCE; REVIEW;

APOPTOSIS; DNA DAMAGE; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; HUMANS; TUMOR CELLS, CULTURED;

EID: 0030630022     PISSN: 09557873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Dive C. Wyllie AH. Programmed cell death and cancer chemotherapy. In: Hickman JA, Tritton TT, eds. Frontiers in Pharmacology: Cancer Chemotherapy. Blackwell Scientific Publications. 1993.
2. Chapman RS. Gregory CD, Dive C. Apoptosis in hematopoiesis and leukemogenesis. In: Whetton AD. Gordon J. eds. Blood Cell Biochemistry: Hematopoietic Cell Growth Factors and their Receptors. New York: Plenum Press, 1996; pp 151-86.